Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07136831

"Short-term Outcome in STEMI Patients Undergoing Primary PCI: A Comparative Study Between Rural and Urban Communities at Assiut University."

this study aims to assess the short-term (3-month) clinical and echocardiographic outcomes of primary PCI among STEMI patients from rural versus urban areas in Upper Egypt. A special focus will be placed on identifying predictors of MACE. The findings may offer valuable insight into optimizing STEMI care pathways and support the development of regional STEMI networks across Egypt.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

About this study

ST-segment elevation myocardial infarction (STEMI) is a life-threatening condition that requires urgent reperfusion therapy, with primary percutaneous coronary intervention (PCI) being the gold standard of care. While PCI significantly reduces complications and improves survival, access to this intervention remains unequal, particularly between rural and urban populations

According to the latest census definitions, a rural area is characterized by:A population of fewer than 5,000,A population density of less than 400 persons per square kilometer,And more than 25% of the male working population engaged in agriculture.

Rural patients often experience delayed diagnosis, limited access to PCI-capable centers, and prolonged ischemic times. These factors contribute to poorer clinical outcomes, including higher rates of reinfarction, heart failure, and mortality. In contrast, urban residents typically have faster access to specialized cardiac care and more efficient treatment pathways.

In Upper Egypt, this urban-rural gap is particularly pronounced, with rural patients facing substantial logistical and systemic challenges in receiving timely PCI. Although efforts have been made to expand PCI access nationwide, there remains a lack of localized data comparing short-term outcomes-particularly major adverse cardiovascular events (MACE)-between rural and urban STEMI patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Adults aged ≥18 years. 2. Confirmed diagnosis of ST-segment elevation myocardial infarction (STEMI) based on ECG and cardiac biomarkers.
  • Underwent primary percutaneous coronary intervention (PCI) within the study period.
  • Known and verified residential address classified as rural or urban based on official definitions (e.g., UK or WHO classification).
  • Informed consent obtained

Exclusion criteria

  • Non-STEMI or unstable angina cases.
  • Patients who received fibrinolytic therapy instead of PCI.
  • Transfer from another facility after more than 12 hours of symptom onset.
  • Patients with previous revascularization (e.g., CABG or PCI within the last 6 months).
  • Incomplete clinical data or unknown residential location.

-

Treatment and study plan

Primary Percutaneous Coronary Intervention (PPCI)

Device

A catheter-based invasive procedure used to open blocked coronary arteries in patients presenting with ST-elevation myocardial infarction (STEMI).

Primary outcomes

  1. Incidence of major adverse cardiovascular events (MACE) among STEMI patients undergoing primary percutaneous coronary intervention (PCI),

    Time frame: 3 month

    Unite of measurement : Number of patients experiencing MACE (% of total)

Study contacts

Contact information is provided by the study sponsor or research team.

Fatma ali khallaf Dr fatma ali

CONTACT

[email protected]

+201000465132

Hatem Abdelrahman, Professor

CONTACT

[email protected]

+20 10 05212162

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

"Short-term Outcome of Patients From Rural Versus Urban Communities Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction"

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 22, 2025
Registry last updated
Aug 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.